Article | October 11, 2023

Aseptic Filling And Processing Considerations For Biosimilars

Source: AST

By Josh Russell


Biosimilar production is an exciting and challenging undertaking for any biopharmaceutical operation. When a patent on a highly effective and valuable biologic expires, a related biologically similar product can be produced, often at a much more accessible price point. Unlike the development of standard generic drugs, biosimilars have a high failure rate during the R&D process and represent a substantial financial investment regardless of success or failure.

The biosimilar market has not been dissuaded by the risk of failure, and it is clear there are remarkable benefits to patient care as these products become more available. The biopharmaceutical industry will continue to find ways to efficiently and effectively produce biosimilar products. Gain further insight into the challenges of biosimilar production, and explore aseptic processing considerations for biosimilars.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online